Albert Einstein College of Medicine

New York, New York
Distinguished Professor Emerita, Department of Molecular Pharmacology

Research

Dr. Horwitz is a pioneer in cancer research, having significantly contributed to development of the anti-cancer drug Taxol®, a natural compound in the Pacific yew tree bark. She discovered how Taxol works to be an effective anti-cancer agent because it binds to a cell’s internal machinery, known as tubulin, and blocks the cancer cell’s ability to replicate. Taxol, one of the most widely prescribed chemotherapy agents, has treated over 1.5 million patients with breast, lung, ovarian, cervical and pancreatic cancers. While Taxol therapy is effective for many patients, resistance to the drug is a clinical problem.

With NFCR support since 2000, Dr. Horwitz discovered that cells express different forms of tubulin, and Taxol’s ability to effectively arrest cancer cell growth depends upon the tubulin type present in a patient’s cancer. Her team is investigating how Taxol interacts with all forms of tubulin which could become the basis to predict whether a patient’s tumor will be sensitive or resistant to the drug. Dr. Horwitz’s research efforts to use natural products for developing cancer therapeutics with minimal toxicity led the research community to discover an additional chemotherapy agent, discodermolide, isolated from a Caribbean Sea sponge. Discodermolide, while effective in killing cancer, is not used in patients due to lung toxicity. Dr. Horwitz and fellow NFCR scientist and chemist, Dr. Amos Smith III, are together leading the charge to create discodermolide variations which can effectively kill cancer without damaging the lungs and inducing an aggressive and drug-resistant property of cancer known as senescence. Development of a clinically adopted version of discodermolide may be effective in treating patients with triple negative breast cancer and other cancers.

Bio

Susan Band Horwitz, Ph.D., is a Distinguished Professor at the Albert Einstein College of Medicine. She is also the co-chair of the Department of Molecular Pharmacology and the Rose C. Falkenstein Chair in Cancer Research.

Dr. Horwitz grew up in Boston, went to Bryn Mawr College and received her Ph.D. in Biochemistry from Brandeis University. Dr. Horwitz worked as a postdoctoral fellow at Tufts University’s Medical School and at Emory University’s School of Medicine. In 1967, she began work at the Albert Einstein College of Medicine.

Dr. Horwitz’s key interest is finding cancer treatments using natural products as a source for new drugs.

Over the course of her career, Dr. Horwitz’s work has been published over 250 times, and she has received numerous accolades including: the C. Chester Stock Award from Memorial Sloan Kettering Cancer Center; the Warren Alpert Foundation Prize from Harvard Medical School; the Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research; the American Cancer Society’s Medal of Honor; the AACR Award for Lifetime Achievement in Cancer Research; the Canada Gairdner International Award; and the Szent-Györgyi Prize for Progress in Cancer Research.

Related Content

New Treatment & Renewed Hope for Triple-negative Breast Cancer Patients

Nut-Consumption and Breast Cancer Survival

Breast cancer is the most common type of cancer among women in the world and, although less common, it can also affect men. An estimated 284,200 new breast cancer cases will be diagnosed in the United States this year, and tragically an estimated 44,130 deaths will occur. While screening and treatment options have become more advanced, it is still important for women to proactively reduce breast cancer risk factors. Thankfully, a team of renowned researchers recently discovered that breast cancer prevention could be as simple as eating a handful of trail mix. Connecting the Dots Researchers from Vanderbilt University Medical Center and the Shanghai Municipal Center of Disease Control and Prevention concluded that nut consumption appeared to be associated with higher survival rates among long-term breast cancer survivors. The researchers suggest emphasizing this finding as a modifiable lifestyle factor in survivor guidelines. The team came to this conclusion after analyzing associations of peanut and tree nut consumption with overall survival (OS) and disease-free survival (DFS) among 3,449 long-term breast cancer survivors aged 20 to 75 years who participated in the Shanghai Breast Cancer Survival Study. Of these participants, 3,148 women reported nut consumption, and 301 women reported no nut consumption. The researchers obtained a detailed dietary assessment, which the women completed at the 5-year post-diagnosis follow-up interview between October 2007 and October 2011. The team converted the consumption of nuts into grams per week and calculated total nut consumption as the sum of intake from peanuts, walnuts, and other nuts. Here’s what they found: Participants who consumed nuts regularly had higher rates of OS and DFS (by 4.7% and 7.9%, respectively) 10 years after diagnosis. There were positive associations of nut consumption with OS and DFS after a dose-response pattern for participants with greater-than-median (17.32 g per week) nut intake compared with non-consumers. The team explained that nuts are a common nutrient-dense food seen in healthy diets. As such, several studies have found nuts to be associated with reduced mortality, particularly mortality due to cardiovascular diseases, in the general population. Previously we knew little on whether the health benefits of nut intake extended to breast cancer survivors, particularly regarding the DFS. The goal of this study was to address this knowledge gap. Which nuts should you be eating? While the study mentions peanuts and walnuts by name, there are a variety of nuts that can offer cancer-fighting benefits. Here’s what experts at National Foundation for Cancer Research (NFCR) have to say: Brazil nuts contain the richest source of natural selenium, a nutrient that may play a critical role in reducing the risk of certain cancers Walnuts have pedunculagin, a tannin that the body metabolizes into urolithins. Urolithins are compounds that bind to estrogen receptors and may play a role in preventing breast cancer. Related NFCR-Supported Research NFCR-funded researchers also point out that while eating cancer-fighting foods is a great step, there are other essential factors to include to prevent various cancers – including breast cancer. Exercise and regular screening (where applicable) are vital in preventing and treating cancer. Recently, NFCR-funded scientist Dr. Rakesh Jain and his team at Massachusetts General […]

Life Happens Quickly: Aly’s Story

As we grow older, we learn to understand that life happens quickly. Aly Newel learned just how quickly things could happen when she was screened for, diagnosed with, and received breast cancer treatment, all within 22 days. After losing her mother to breast cancer, Aly devotedly underwent her mammograms as recommended since turning 30 years old. In early 2016, she suddenly realized that she had missed her annual appointment by nearly six months. She quickly made an appointment, not thinking too much about the lapse as everything felt normal.  “My general practitioner told me that the test had detected abnormal cells in my left breast and that she was referring me to a surgeon,” Aly shared. “It wasn’t more than a couple of days before I was with the breast surgeon in absolute shock at how quickly this had happened. With everything that happened with my mom, I was scared.” Aly soon received the biopsy results that quickly filled her with dread as she learned she had breast cancer. Luckily, the ductal carcinoma in-situ was in the early stages and completely treatable.  “I was stunned,” Aly reflected. “How can he have just told me that I have breast cancer, yet it is curable? Honestly, it took me a while to get my head around that.” Before she could fully wrap her head around the news, Aly had a hook wire insertion and lumpectomy.  “These operations sound really scary, but they aren’t at all,” Aly said. “The surgeon came to see me after the operation and told me that everything had gone really well and that the cancer was gone.” Aly felt amazing – pain-free and thrilled to be rid of the nasty disease. She had zero pain and only a little scar on her left breast for which to remember the whirlwind experience. With just a single dose of radiotherapy, she closed this scary yet short chapter.  “I would like to share my story because as a mother of two daughters, I feel that it’s really important to promote early detection by encouraging women to become familiar with the regular feel of their breasts and participate in the screening programs that they are eligible for,” Aly stated. “I also think it’s important for people to realize that being diagnosed with breast cancer doesn’t necessarily have a bad outcome if it’s found early.” Life happens quickly, and sometimes it is easy to forget the small steps that make a big difference – like scheduling regular mammograms. Luckily, the National Foundation for Cancer Research (NFCR) has you covered. Follow NFCR on social media or check out our Cancer-Fighting Lifestyle Tips to keep you and your loved ones safe.  Additional Reads You May Enjoy: Let’s talk about Mammograms with Dr. Alexia Matheson Don’t Delay: Skipping One Mammogram Can Significantly Increase Risk of Death from Breast Cancer Mastectomy and Breast Reconstruction: What Breast Cancer Patients Should Know   Stay connected with the cancer community! Receive NFCR’s monthly e-newsletter and blogs featuring stories of inspiration, support resources, cancer prevention tips, and more. Sign up here.